- Home
- LSH vs NMTC Comparison
LSH vs NMTC Comparison
Compare LSH & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSH
- NMTC
- Stock Information
- Founded
- LSH 2018
- NMTC 2009
- Country
- LSH United States
- NMTC United States
- Employees
- LSH N/A
- NMTC N/A
- Industry
- LSH
- NMTC Medical/Dental Instruments
- Sector
- LSH
- NMTC Health Care
- Exchange
- LSH NYSE
- NMTC Nasdaq
- Market Cap
- LSH 20.3M
- NMTC 21.0M
- IPO Year
- LSH 2024
- NMTC N/A
- Fundamental
- Price
- LSH $2.00
- NMTC $0.97
- Analyst Decision
- LSH
- NMTC
- Analyst Count
- LSH 0
- NMTC 0
- Target Price
- LSH N/A
- NMTC N/A
- AVG Volume (30 Days)
- LSH 373.0K
- NMTC 275.8K
- Earning Date
- LSH 02-10-2025
- NMTC 02-11-2025
- Dividend Yield
- LSH N/A
- NMTC N/A
- EPS Growth
- LSH N/A
- NMTC N/A
- EPS
- LSH N/A
- NMTC N/A
- Revenue
- LSH $18,248,233.00
- NMTC $3,453,003.00
- Revenue This Year
- LSH N/A
- NMTC $292.88
- Revenue Next Year
- LSH N/A
- NMTC N/A
- P/E Ratio
- LSH N/A
- NMTC N/A
- Revenue Growth
- LSH 28.38
- NMTC 1.33
- 52 Week Low
- LSH $1.78
- NMTC $0.55
- 52 Week High
- LSH $5.37
- NMTC $1.59
- Technical
- Relative Strength Index (RSI)
- LSH N/A
- NMTC 45.04
- Support Level
- LSH N/A
- NMTC $1.02
- Resistance Level
- LSH N/A
- NMTC $1.31
- Average True Range (ATR)
- LSH 0.00
- NMTC 0.15
- MACD
- LSH 0.00
- NMTC -0.02
- Stochastic Oscillator
- LSH 0.00
- NMTC 12.67
About LSH LAKESIDE HOLDING LTD
Lakeside Holding Ltd i an integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea. It provides customized cross-border ocean freight solutions and airfreight solutions in the U.S, including cross-border freight consolidation and forwarding services; customs clearance services; warehousing and distribution services and U.S. domestic ground transportation services.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.